Stay updated on Avelumab Program Rollover Study Clinical Trial
Sign up to get notified when there's something new on the Avelumab Program Rollover Study Clinical Trial page.

Latest updates to the Avelumab Program Rollover Study Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this is a metadata update and does not alter study content or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedThe government funding notice about updates and processing status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedNo meaningful content changes detected; the study details and locations appear unchanged compared with the prior view.SummaryDifference0.2%

- Check63 days agoChange DetectedNew operating-status notice and v3.2.0 release; prior v3.1.0 revision removed.SummaryDifference3%

- Check71 days agoChange DetectedUpdate version tag to v3.1.0; removal of the term 'Ovarian cancer' with no other substantive content changes.SummaryDifference0.1%

- Check85 days agoChange DetectedLocalization update: México is used instead of Mexico. The page version moved to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.2%

Stay in the know with updates to Avelumab Program Rollover Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Program Rollover Study Clinical Trial page.